Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ravindra DeSilva"'
Publikováno v:
Pharmaceuticals, Vol 5, Iss 1, Pp 79-93 (2012)
The human epidermal growth factor receptor 2 (HER2/neu) is overexpressed in 20–30% of breast cancers and is associated with tumor growth, angiogenesis, and development of distant metastases. Trastuzumab, an anti-HER2 monoclonal antibody, is used fo
Externí odkaz:
https://doaj.org/article/90d229163f88483398bd8b0342f331f4
Autor:
Ronnie C. Mease, Bryan Wharram, Sridhar Nimmagadda, Akhilesh Mishra, Ravindra Desilva, Ala Lisok, Dhiraj Kumar, Sagar Shelake
Publikováno v:
Cancer Research. 80:3448-3448
Introduction. Blockade of programmed death ligand-1 (PD-L1) and its receptor (PD-1) has emerged as a foundational treatment strategy for cancer. Immunohistochemical analysis (IHC) of PD-L1 expression is one of the biomarkers used to guide those treat
Autor:
Buck E. Rogers, Albert J. Chang, Ravindra DeSilva, Suzanne E. Lapi, Sandeep Jain, Kimberley Lears
Publikováno v:
Pharmaceuticals, Vol 5, Iss 1, Pp 79-93 (2012)
Pharmaceuticals; Volume 5; Issue 1; Pages: 79-93
Pharmaceuticals
Pharmaceuticals (Basel, Switzerland), vol 5, iss 1
Pharmaceuticals; Volume 5; Issue 1; Pages: 79-93
Pharmaceuticals
Pharmaceuticals (Basel, Switzerland), vol 5, iss 1
The human epidermal growth factor receptor 2 (HER2/neu) is overexpressed in 20-30% of breast cancers and is associated with tumor growth, angiogenesis, and development of distant metastases. Trastuzumab, an anti-HER2 monoclonal antibody, is used for
Autor:
Chang, Albert J.1 achang@radonc.wustl.edu, DeSilva, Ravindra2 deslivar@mir.wustl.edu, Jain, Sandeep2 Sandeep.Jain@sparcmail.com, Lears, Kimberley1 klears@radonc.wustl.edu, Rogers, Buck1 brogers@radonc.wustl.edu, Lapi, Suzanne2 lapis@mir.wustl.edu
Publikováno v:
Pharmaceuticals (14248247). Mar2012, Vol. 5 Issue 1, p79-93. 15p. 3 Color Photographs, 3 Graphs.
Autor:
Vanden Eynde, Jean Jacques1 jean-jacques.vandeneynde@ex.umons.ac.be
Publikováno v:
Pharmaceuticals (14248247). 2015, Vol. 8 Issue 2, p277-278. 2p.